297 related articles for article (PubMed ID: 15718537)
1. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.
Gunnell D; Saperia J; Ashby D
BMJ; 2005 Feb; 330(7488):385. PubMed ID: 15718537
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.
Martinez C; Rietbrock S; Wise L; Ashby D; Chick J; Moseley J; Evans S; Gunnell D
BMJ; 2005 Feb; 330(7488):389. PubMed ID: 15718538
[TBL] [Abstract][Full Text] [Related]
3. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
4. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
5. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis.
Dubicka B; Hadley S; Roberts C
Br J Psychiatry; 2006 Nov; 189():393-8. PubMed ID: 17077427
[TBL] [Abstract][Full Text] [Related]
6. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
7. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?
Hall WD; Lucke J
Aust N Z J Psychiatry; 2006; 40(11-12):941-50. PubMed ID: 17054562
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.
Jakobsen JC; Katakam KK; Schou A; Hellmuth SG; Stallknecht SE; Leth-Møller K; Iversen M; Banke MB; Petersen IJ; Klingenberg SL; Krogh J; Ebert SE; Timm A; Lindschou J; Gluud C
BMC Psychiatry; 2017 Feb; 17(1):58. PubMed ID: 28178949
[TBL] [Abstract][Full Text] [Related]
9. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.
Fergusson D; Doucette S; Glass KC; Shapiro S; Healy D; Hebert P; Hutton B
BMJ; 2005 Feb; 330(7488):396. PubMed ID: 15718539
[TBL] [Abstract][Full Text] [Related]
10. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
11. [SSRIs (selective serotonin reuptake inhibitors) and suicidality in adults, adolescents and children].
Tandt H; Audenaert K; van Heeringen C
Tijdschr Psychiatr; 2009; 51(6):387-93. PubMed ID: 19517368
[TBL] [Abstract][Full Text] [Related]
12. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
Khan A; Khan S; Kolts R; Brown WA
Am J Psychiatry; 2003 Apr; 160(4):790-2. PubMed ID: 12668373
[TBL] [Abstract][Full Text] [Related]
13. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
14. Use of selective serotonin reuptake inhibitors in children and adolescents.
Wong IC; Besag FM; Santosh PJ; Murray ML
Drug Saf; 2004; 27(13):991-1000. PubMed ID: 15471506
[TBL] [Abstract][Full Text] [Related]
15. The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study.
Wheeler BW; Gunnell D; Metcalfe C; Stephens P; Martin RM
BMJ; 2008 Mar; 336(7643):542-5. PubMed ID: 18276667
[TBL] [Abstract][Full Text] [Related]
16. Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication.
Didham RC; McConnell DW; Blair HJ; Reith DM
Br J Clin Pharmacol; 2005 Nov; 60(5):519-25. PubMed ID: 16236042
[TBL] [Abstract][Full Text] [Related]
17. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
Healy D
Psychother Psychosom; 2003; 72(2):71-9. PubMed ID: 12601224
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants and suicide: risk of completed suicide is not the same as risk of deliberate self harm.
Mitchell AJ
BMJ; 2004 Aug; 329(7463):461; author reply 461-2. PubMed ID: 15321923
[No Abstract] [Full Text] [Related]
19. Drop-out rates in placebo-controlled trials of antidepressant drugs: A systematic review and meta-analysis based on clinical study reports.
Sharma T; Guski LS; Freund N; Meng DM; Gøtzsche PC
Int J Risk Saf Med; 2019; 30(4):217-232. PubMed ID: 31561390
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
